Inhibitors of multidrug resistance (MDR) have affinity for MDR substrates

Mire Zloh, Glenn W. Kaatz, Simon Gibbons

Research output: Contribution to journalArticlepeer-review

37 Citations (Scopus)

Abstract

Multidrug-resistance (MDR) occurs in many bacterial species and tumour cells. MDR functions by membrane proteins which export drugs from cells, resulting in a low ineffective concentration of the drug. We have shown by molecular modelling that inhibitors of MDR have affinity for substrates of MDR transporters. This affinity may facilitate drug entry into cells and a large inhibitor–drug complex may be a poorer substrate for the MDR mechanism. This complex would effectively ‘cloak’ the drug rendering it unavailable for efflux.

Here we show by molecular modelling that inhibitors of MDR have affinity for substrates of MDR transporters.
Original languageEnglish
Pages (from-to)881-885
Number of pages5
JournalBioorganic & Medicinal Chemistry Letters
Volume14
Issue number4
DOIs
Publication statusPublished - 23 Feb 2004

Cite this